載入...

Viability of a Drug-Resistant Human Immunodeficiency Virus Type 1 Protease Variant: Structural Insights for Better Antiviral Therapy

Under the selective pressure of protease inhibitor therapy, patients infected with human immunodeficiency virus (HIV) often develop drug-resistant HIV strains. One of the first drug-resistant mutations to arise in the protease, particularly in patients receiving indinavir or ritonavir treatment, is...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Prabu-Jeyabalan, Moses, Nalivaika, Ellen A., King, Nancy M., Schiffer, Celia A.
格式: Artigo
語言:Inglês
出版: American Society for Microbiology 2003
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC140781/
https://ncbi.nlm.nih.gov/pubmed/12502847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.77.2.1306-1315.2003
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!